Nucleus

New York, United States

Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.

$14.0M raised

Jan 2025

Series A

Top Investors

Founders FundQuiet CapitalNeoSeven Seven SixShrug Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nucleus raised?

Nucleus has raised $14.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.

Who are Nucleus's investors?

Nucleus's investors include Founders Fund, Quiet Capital, Neo, Seven Seven Six, Shrug Capital.

Where is Nucleus headquartered?

Nucleus is headquartered in New York, United States.

What does Nucleus do?

Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.

What stage is Nucleus at?

Nucleus is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 30, 2025.

MLA

"Nucleus — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/nucleus-new-york. Accessed June 4, 2026.

APA

VCBacked. (2025). Nucleus — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nucleus-new-york

Wikipedia (cite web)

{{cite web |title=Nucleus — Funding & Investors |url=https://www.vcbacked.co/company/nucleus-new-york |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 30, 2025.